INCI · — · CIR review pending · used in 2 products
솔비탄트라이스테아레이트
SORBITAN TRISTEARATE
Evidence level
moderateEWG score
—Comedogenic
—Category
—● Benefits
Benefits to be documented.
● Cautions
No known cautions documented in the catalog.
Benefits to be documented.
No known cautions documented in the catalog.